156 related articles for article (PubMed ID: 32677450)
1. Challenges of Screening Prospective Stool Donors for Fecal Microbiota Transplantation.
Dubois NE; Read CY; O'Brien K; Ling K
Biol Res Nurs; 2021 Jan; 23(1):21-30. PubMed ID: 32677450
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.
He J; He X; Ma Y; Yang L; Fang H; Shang S; Xia H; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Zhai C; Wang W; Jiang X; Xuan J; Liu M; Lu S; Li X; Wang H; Ouyang C; Cao M; Lin A; Zhang B; Wu D; Chen Y; Xiao C
Microb Cell Fact; 2021 Nov; 20(1):216. PubMed ID: 34838016
[TBL] [Abstract][Full Text] [Related]
3. Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank.
Ianiro G; Porcari S; Bibbò S; Giambò F; Quaranta G; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
Dig Liver Dis; 2021 Nov; 53(11):1428-1432. PubMed ID: 34030988
[TBL] [Abstract][Full Text] [Related]
4. In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation.
McSweeney B; Allegretti JR; Fischer M; Xu H; Goodman KJ; Monaghan T; McLeod C; Mullish BH; Petrof EO; Phelps EL; Chis R; Edmison A; Juby A; Ennis-Davis R; Roach B; Wong K; Kao D
Gut Microbes; 2020; 11(1):51-62. PubMed ID: 31122134
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.
Yau YK; Mak WYJ; Lui NSR; Ng WYR; Cheung CYK; Li YLA; Ching YLJ; Chin ML; Lau HSL; Chan KLF; Chan KSP; Ng SC
United European Gastroenterol J; 2021 Nov; 9(9):1027-1038. PubMed ID: 34623758
[TBL] [Abstract][Full Text] [Related]
6. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
[TBL] [Abstract][Full Text] [Related]
7. Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection.
Tariq R; Weatherly R; Kammer P; Pardi DS; Khanna S
J Clin Gastroenterol; 2018 Feb; 52(2):146-150. PubMed ID: 27984397
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
9. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank.
Chen J; Zaman A; Ramakrishna B; Olesen SW
Front Cell Infect Microbiol; 2021; 11():622949. PubMed ID: 33937092
[TBL] [Abstract][Full Text] [Related]
10. Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes.
Anand R; Song Y; Garg S; Girotra M; Sinha A; Sivaraman A; Phillips L; Dutta SK
Dig Dis Sci; 2017 Apr; 62(4):1002-1008. PubMed ID: 28181098
[TBL] [Abstract][Full Text] [Related]
11. Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank.
Seo HS; Chin HS; Kim YH; Moon HS; Kim K; Nguyen LP; Yong D
Ann Lab Med; 2021 Jul; 41(4):424-428. PubMed ID: 33536363
[TBL] [Abstract][Full Text] [Related]
12. Challenges and costs of donor screening for fecal microbiota transplantations.
Bénard MV; de Bruijn CMA; Fenneman AC; Wortelboer K; Zeevenhoven J; Rethans B; Herrema HJ; van Gool T; Nieuwdorp M; Benninga MA; Ponsioen CY
PLoS One; 2022; 17(10):e0276323. PubMed ID: 36264933
[TBL] [Abstract][Full Text] [Related]
13. Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.
Kim KO; Schwartz MA; Lin OST; Chiorean MV; Gluck M
Adv Ther; 2019 Aug; 36(8):2052-2061. PubMed ID: 31154629
[TBL] [Abstract][Full Text] [Related]
14. [Association between the clinical efficacy of fecal microbiota transplantation in recipients and the choice of donor].
Chen QY; Yang B; Tian HL; Lin ZL; Zhao D; Ye C; Zhang XY; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):69-76. PubMed ID: 32594729
[No Abstract] [Full Text] [Related]
15. Donor Recruitment for Fecal Microbiota Transplantation.
Paramsothy S; Borody TJ; Lin E; Finlayson S; Walsh AJ; Samuel D; van den Bogaerde J; Leong RW; Connor S; Ng W; Mitchell HM; Kaakoush N; Kamm MA
Inflamm Bowel Dis; 2015 Jul; 21(7):1600-6. PubMed ID: 26070003
[TBL] [Abstract][Full Text] [Related]
16. Stool donor recruitment - A one-year experience.
Aira A; Rubio E; Fehér C; González-Suárez B; Casals-Pascual C; Soriano Á
Enferm Infecc Microbiol Clin (Engl Ed); 2022 Nov; 40(9):495-498. PubMed ID: 36336379
[TBL] [Abstract][Full Text] [Related]
17. Eligible blood donors' decisions about donating stool for fecal microbiota transplantation: Does ambivalence play a role?
Hyde MK; Masser BM
Transfusion; 2021 Feb; 61(2):474-483. PubMed ID: 33006187
[TBL] [Abstract][Full Text] [Related]
18. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of feces donors among blood donors: Results from an observational cohort study.
Jørgensen SMD; Erikstrup C; Dinh KM; Lemming LE; Dahlerup JF; Hvas CL
Gut Microbes; 2018 Nov; 9(6):540-550. PubMed ID: 29617178
[TBL] [Abstract][Full Text] [Related]
20. Establishing a donor stool bank for faecal microbiota transplantation: methods and feasibility.
Rode AA; Bytzer P; Pedersen OB; Engberg J
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1837-1847. PubMed ID: 31273647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
